Several studies have shown that HDAC inhibitors such as sodium butyrate (NaB), suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA) significantly inhibited neuroblastoma cell growth [17], [18], [19]. This evidence concerns the gene HDAC9 and neuroblastoma.